Interactions among HIV gp120, CD4, and CXCR4: Dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies

Virology

Volumn 248, Issue 2, 1998, Pages 394-405

  Mondor, Isabelle ^a   Moulard, Maxime ^a   Ugolini, Sophie ^a   Klasse, P J ^b   Hoxie, J ^c   Amara, Ali ^d   Delaunay, Thierry ^e   Wyatt, Richard ^f   Sodroski, Joseph ^f   Sattentau, Quentin J ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d INSTITUT PASTEUR   (France)

^e INRA   (France)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CONFORMATIONAL TRANSITION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTE COUNT; MEMBRANE FUSION; PRIORITY JOURNAL; SYNCYTIUM; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS PARTICLE;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0032169831     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9282     Document Type: Article

References (70)

1. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A rantes, MIP-1a, MIP-1b receptor as a fusion cofactor for macrophage tropic HIV-1. Science. 272:1996;1955-1959.
2. Bandres J. C., Wang Q. F., O'Leary J., Baleux F., Amara A., Hoxie J. A., Zolla-Pazner S., Gorny M. K. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation. J. Virol. 72:1998;2500-2504.
3. Berger E. A. HIV entry and tropism: The chemokine receptor connection. AIDS. 11:1997;S3-S16.
4. Berger E. A., Doms R. W., Fenyo E.-M., Korber B. T. M., Littman D. R., Moore J. P., Sattentau Q. J., Schuitemaker H., Sodroski J., Weiss R. A. HIV-1 phenotypes classified by co-receptor usage. Nature. 391:1997;240.
5. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-832.
6. Bour S., Geleziunas R., Wainberg M. A. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol. Rev. 59:1995;63-93.
7. Brelot A., Heveker N., Pleskoff O., Sol N., Alizon M. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J. Virol. 71:1997;4744-4751.
8. Burton D. R., Pyati J., Koduri R., Sharp S. J., Thornton G. B., Parren P. W., Sawyer L. S., Hendry R. M., Dunlop N., Nara P. L., Burton D. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal a ntibody. Science. 266:1994;1024-1027.
9. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. Cell. 85:1996;1135-1148.
10. Clapham P., McKnight A., Simmons G., Weiss R. Is CD4 sufficient for HIV entry? Cell surface molecules involved in HIV infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 342:1993;67-73.
11. Clements G. J., J. P.-J. M., Stephens P. E., Sutton C., Schulz T. F., Clapham P. R., McKeating J. A., McClure M. O., Thomson S., Marsh M., Kay J., Weiss R. A., Moore J. P. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: A possible function in viral fusion. AIDS Res. Hum. Retroviruses. 7:1991;3-16.
12. Cocci F., DeVico A. L., Garzino-Demo A., Cara A., Gallo R. C., Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine- mediated blockade of infection. Nature Med. 2:1996;1244-1247.
13. Conley A. J., Gorny M. K., Kessler J. A., Boots L. J., Ossorio-Castro M., Koenig S., Lineberger D. W., Emini E. A., Williams C., Zolla-Pazner S. Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. J. Virol. 68:1994;6994-7000.
14. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
15. di Marzo Veronese F., Rahman R., Pal R., Boyer C., Romano J., Kalyanaraman V. S., Nair B. C., Gallo R. C., Sarngadharan M. G. Delineation of immunoreactive, conserved regions in the external envelope glycoprotein of the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 8:1992;1125-1132.
16. Doms R. W., Peiper S. C. Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry. Virology. 235:1997;179-190.
17. Doranz B., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the b-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
18. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
19. Dragic T., Trkola A., Lin S. W., K. A. N., Kajumo F., Zhao L., Olson W. C., Wu L., Mackay C. R., Allaway G. P., Sakmar T. P., Moore J. P., Maddon J. P. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J. Virol. 72:1998;279-285.
20. Endres M. J., Clapham P. R., Marsh M., Ahuja M., Davis-Turner J., McKnight A., Thomas J. F., Stoebenau-Haggarty B., Choe S., Vance P. J., Wells T. N. C., Power C. A., Sutterwala S. S., Doms R. W., Landau N. R., Hoxie J. A. CD4-independent infection by HIV-2 is mediated by Fusin/CXCR-4. Cell. 87:1996;745-765.
21. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
22. Forster R., Kremmer E., Schubel A., Breitfelld D., Kleinschmidt A., Nerl C., Bernhardt G., Lipp M. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/Fusin on various leukocyte subsets: Rapid internalization and recycling upon activation. J. Immunol. 160:1998;1522-1531.
23. Gorny M. K., Conley S., Karwowska A., Buchbinder A., Xu J.-Y., Emini E. A., Koenig S., Zolla-Pazner S. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66:1992;7538-7542.
24. Groenink M., Fouchier R. A. M., de Goede R. E. Y., de Wolf F., Gruters R. A., Cuypers H. T. M., Huisman H. G., Tersmette M. Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J. Virol. 65:1991;1968-1975.
25. Healey D., Dianda L., Moore J. P., McDougal J. S., Moore M. J., Estess P., Buck D., Kwong P. D., Beverley P. C. L., Sattentau Q. J. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J. Exp Med. 172:1990;1233-1242.
26. Hesselgesser J., Halks-Miller M., DelVeccio V., Peiper S. C., Hoxie J., Kolson D. L., Taub D., Horuk R. CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons. Curr.Biol. 7:1997;112-121.
27. Hill C. M., Deng H., Unutmaz D., Kewalramani V. N., Bastiani L., Gorny M. K., Zolla-Pazner S., Littman D. R. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian impmunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:1997;6296-6304.
28. Ivey-Hoyle M., Culp J. S., Chaikin M. A., Hellmig B. D., Matthews T. J., Sweet R. W., Rosenberg M. Envelope glycoproteins from biologically diverse isolates of human immunodeficiency viruses have widely different affinities for CD4. Proc. Natl. Acad. Sci. USA. 88:1991;512-516.
29. LaCasse R. A., Follis K. E., Moudgil T., Trahey M., Binley J., Planelles V., Zolla-Pazner S., Nunberg J. H. Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity. J. Virol. 72:1998;2491-2495.
30. Lapham C. K., Ouyang J., Chandrasekhar B., Kguyen N. Y., Dimitrov D. S., Golding H. Evidence for cell-surface association between fusin and the CD4- gp120 complex in human cell lines. Science. 274:1996;602-605.
31. Levy, J. 1994, HIV and the pathogenesis of AIDS, American Society for Microbiology, Washington, D.C.
32. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
33. Lu Z., Berson J. F., Chen Y., Turner J. D., Zhang T., Sharron M., Jenks M. H., Wang Z., Kim J., Rucker J., Hoxie J. A., Peiper S. C., Doms R. W. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA. 94:1997;6426-6431.
34. Martin K. A., Wyatt R., Farzan M., Choe H., Marcon L., Desjardins E., Robinson J., Sodroski J., Gerard C., Gerard N. P. CD4-independent binding of SIV gp120 to rhesus CCR5. Science. 278:1997;1470-1472.
35. McCutchan F. E., Hegerich P. A., Brennan T. P., Phanuphak P., Singharaj P., Jugsudee A., Berman P. W., Gray A. M., Fowler A. K., Burke D. S. Genetic variants of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses. 8:1992;1887-1895.
36. McKnight A., Wilkinson D., Simmons G., Picard L., Ahuja M., Marsh M., Hoxie J. A., Clapham P. R. Inhibition of HIV fusion by a monoclonal antibody to a co-receptor (Lestr) is both cell type and virus strain dependent. J. Virol. 71:1997;1692-1696.
37. Mondor I., Ugolini S., Sattentau Q. J. HIV-1 attachment to HeLa CD4 cells is CD4-independent, gp120 dependent and requires cell surface heparans. J. Virol. 72:1998;3623-3634.
38. Montefiori D. C., Collman R. G., Fouts T. R., Zhou J. Y., Bilska M., Hoxie J. A., Moore J. P., Bolognesi D. P. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J. Virol. 72:1998;1886-1893.
39. Moore J. P., Cao Y., Qing L., Sattentau Q. J., Pyati J., Koduri R., Robinson J., Barbas C. F. r., Burton D. R., Ho D. D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:1995a;101-109.
40. Moore, J. P. Jameson, B. A. Weiss, R. A. Sattentau, Q. J. 1993, The HIV-cell fusion reaction, In, Viral Fusion Mechanisms, 233, 291, CRC Press, Boca Raton.
41. Moore J. P., Morikawa Y., Jones I. M. Binding of recombinant HIV-1 and HIV-2 SU glycoproteins to sCD4. J. Acquired Immune Def. Syndr. 4:1991;442-449.
42. Moore J. P., Sattentau Q. J., Wyatt R., Sodroski J. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:1994;469-484.
43. Moore J. P., Trkola A., Dragic T. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9:1997;551-562.
44. Moore J. P., Trkola A., Korber B., Boots L. J., Kessler J. A. N., McCutchan F. E., Mascola J., Ho D. D., Robinson J., Conley A. J. A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B. J. Virol. 69:1995b;122-130.
45. Moulard M., Achstetter T., Montagnier L., Kieny M.-P., Bahraoui E. Kex2p: A model for cellular endoprotease processing of the HIV-1 envelope glycoprotein precursor. Eur. J. Biochem. 225:1994;565-572.
46. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Ruker F., Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:1993;6642-6647.
47. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.-L., Arenzana-Seisdedos F., Schwartz O., Heard J.-M., Clark-Lewis I., Legler D. F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
48. Paxton W. A., Martin S. R., Tse D., O'Brien T. R., Skurnik J., VanDevanter N. L., Padian N., Braun J. F., Kotler D. P., Wolinsky S. M., Koup R. A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat. Med. 2:1996;412-417.
49. Prince A. M., Horowitz B., Baker L., Schulman R. W., Ralph H., Valinski J., Cundell A., Brotman B., Boehle W., Rey F., Piet M., Reesink H., Lelie N., Tersmette M., Barbosa L., Nemo G., Nastala C. L., Allan J. S., Lee D. R., Eichberg J. W. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc. Natl. Acad. Sci. USA. 85:1988;6944-6948.
50. Roderiquez G., Oravecz T., Yanagishita M., Bou-Habib D. C., Mostowski H., Norcross M. A. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol. 69:1995;2233-2239.
51. Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C.-M., Saragosti S., Lapoumerouli C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R. J., Collman R. G., Doms R. W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
52. Sattentau Q. J., Moore J. P. The role of CD4 in HIV binding and entry. Philos. Trans. R. Soc. Lond. B Biol. Sci. 342:1993;59-66.
53. Sattentau Q. J., Moore J. P. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182:1995;185-196.
54. Sattentau Q. J., Weiss R. A. The CD4 antigen: Physiological ligand and HIV receptor. Cell. 52:1988;631-632.
55. Signoret N., Poignard P., Blanc D., Sattentau Q. J. Human and simian immunodeficiency viruses: Virus-receptor interactions. Trends Microbiol. 1:1993;328-333.
56. Sol N., Ferchal F., Braun J., Pleskoff O., Tréboute C., Ansart I., Alizon M. Usage of the coreceptors CCR-5, CCR-3 and CXCR4 by primary and cell line-adapted human immunodeficiency virus type 2. J. Virol. 71:1997;8237-8244.
57. Strizki J. M., Turner J. D., Collman R. G., Hoxie J., Gonzalez-Scarano F. A monoclonal antibody (12G5) directed against CXCR4 inhibits infection with the dual- tropic human immunodeficiency virus type 1 HIV-1 89.6 but not the T-tropic isolate HIV-1 HxB2. J. Virol. 71:1997;5678-5683.
58. Sullivan N., Sun Y., Sattentau Q. J., Thali M., Wu D., Denisova G., Gershoni J., Robinson J., Moore J., Sodroski J. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72:1998;4694-4703.
59. Sweet R. A., Truneh A., Hendrickson W. A. CD4: Its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target. Curr. Opin. BioTechnol. 2:1991;622-633.
60. Tanchou G., Delauney T., Bodeus M., Roques B. P., Darlix J.-L., Benarous R. Conformational changes between human immunodeficiency virus type 1 nucleocapsid protein Ncp7 and its precursor Ncp15 as detected by anti-Ncp7 monoclonal antibodies. J. Gen. Virol. 76:1995;2457-2466.
61. Thali M., Moore J. P., Furman C., Charles M., Ho D. D., Robinson J., Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:1993;3978-3988.
62. Trkola A., Dragic T., Arthos J., Binley J. M., Olson W. C., Allaway G. P., Cheng-Mayer C., Robinson J., Maddon P. J., Moore J. P. CD4-dependent, antibody sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996a;184-187.
63. Trkola A., Ketas T., Kewalramani V. N., Endorf F., Binley J., Katinger H. R., Littman D. R., Moore J. P. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J. Virol. 72:1998;1876-1885.
64. Trkola A., Pomales A. B., Yuan H., Korber B., Maddon P. J., Allaway G. P., Katinger H., Barbas C. F. III, Burton D., Ho D. D., Moore J. P. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 69:1995;6609-6617.
65. Trkola A., Purtscher M., Muster T., Ballaun C., Buchacher A., Sullivan N., Srinivasan K., Sodroski J., Moore J., Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1996b;1100-1108.
66. Ugolini S., Mondor I., Parren P. W. H. I., Burton D. R., Tilley S., Klasse P.-J., Sattentau Q. J. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization. J. Exp. Med. 186:1997a;1287-1298.
67. Ugolini S., Moulard M., Mondor I., Barois N., Demandolx D., Hoxie J., Brelot A., Alizon M., Davoust J., Sattentau Q. J. HIV-1 gp120 binding to CD4+ cells induces an interaction between CD4, gp120 and the chemokine receptor CXCR415. J. Immunol. 9:1997b;3000-3008.
68. Warrier S. V., Pinter A., Honnen W. J., Girard M., Muchmore E., Tilley S. A. A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognised by a highly potent, neutralizing chimpanzee monoclonal antibody. J. Virol. 68:1994;4636-4642.
69. Wu L., Geradr N. P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A. A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:1996;179-183.
70. Wyatt R., Moore J., Accola M., Desjardin E., Robinson J., Sodroski J. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J. Virol. 69:1995;5723-5733.